Clinical Specimen Collection From Pompe Disease Patients

UnknownOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

May 31, 2023

Conditions
Pompe Disease
Interventions
DRUG

Filgrastim

5 days of daily sub-cutaneous administration of 10mcg/kg filgrastim

Trial Locations (1)

91602

RECRUITING

Seraph Research Institute, Toluca Lake

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Frida Therapeutics LLC

UNKNOWN

lead

Serhat Gumrukcu, MD PhD

OTHER

NCT04476550 - Clinical Specimen Collection From Pompe Disease Patients | Biotech Hunter | Biotech Hunter